Abstract
Study Objectives To determine the prevalence of obstructive sleep apnea (OSA) in adults with Down syndrome (DS), to investigate factors related to OSA severity and to identify which sleep questionnaire is the most appropriate for the screening of OSA in this population.
Methods Cross-sectional study that consecutively included 60 adults with DS. All patients underwent type III polysomnography and clinical and laboratory data were collected; sleep assessment questionnaires were applied. Multiple linear regression models evaluated the associations between OSA severity (measured by the respiratory event index - REI) and clinical and laboratory data and sleep questionnaires (Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, BERLIN and STOP-Bang questionnaires).
Results Results show that 60 (100%) adults with DS had OSA, with moderate-severe OSA identified in 49 (81.6%). At the multivariate linear regression, REI significantly correlated with hematocrit levels, BMI and STOP-Bang questionnaire (SBQ) results (P <0.001). The positive STOP-Bang ≥3 points) showed 100% of sensitivity (95%CI: 92.75-100%), 45.45% of specificity (95%CI: 16.75-76.62), positive predictive value of 89.09% (95%CI: 82.64-93.34%), negative predictive value of 100%, accuracy of 90% (95%CI: 79.49-96.24%) and OR of 24.29.
Conclusions Adults with DS have a very high prevalence of OSA. Hematocrit levels, BMI and SBQ showed a strong correlation with OSA severity. The SBQ performed well in identifying moderate to severe OSA in this population. Considered together, these results point to the need to perform OSA screening in all adults with DS, and STOP-Bang may play a role in this screening.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study received financial support through process number 064.000.560/2015 of Public Notice number 40 of 10/29/2015, published in DODF n. 213, of 11/06/2015, regarding the Homologation of the Final Selection Result of Research Projects to be funded by Fundação de Ensino e Pesquisa em Ciências da Saúde (FEPECS).
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Footnotes
Conflicts of Interest The authors declare that they have viewed and approved the manuscript and that the opinions expressed in the submitted article are theirs and not an official position of the institution or the funder. This study was not supported by the industry. The other authors have no conflicts of interest to declare.
Sources of Funding The study received financial support through process number 064.000.560/2015 of Public Notice number 40 of 10/29/2015, published in DODF n. 213, of 11/06/2015, regarding the Homologation of the Final Selection Result of Research Projects to be funded by Fundação de Ensino e Pesquisa em Ciências da Saúde (FEPECS).
Data Availability
All files used to write the manuscript are available in a public database repository.
